2.3.1.37	2-allyl-2-isopropylacetamide	strong induction of enzyme in liver	486820, 486850	
2.3.1.37	Activator protein	from rat liver mitochondria possibly activates by formation of high molecular weight aggregates of delta-aminolevulinic acid synthetase	486822	
2.3.1.37	Activator protein	from Rhodopseudomonas sphaeroides	486830	
2.3.1.37	ATP	activates in assays with crude enzyme extracts	486809	
2.3.1.37	ATP	slight activation, erythroid-specific isoform	486848	
2.3.1.37	Butyric acid	induction of enzyme expression, erythroleukemia cells	486847	
2.3.1.37	carbamazepine	-	757560	
2.3.1.37	ClpX	the mitochondrial AAA+ unfoldase ClpX participates in both heme-dependent degradation of the enzyme and its activation	758234	
2.3.1.37	CoA	activates	486809	
2.3.1.37	Dimethylsulfoxide	induction of enzyme expression, erythroleukemia cells	486847	
2.3.1.37	dithiothreitol	activates	486811	
2.3.1.37	EDTA	required	486842	
2.3.1.37	estrogen	-	757560	
2.3.1.37	ethanol	-	757560	
2.3.1.37	ethinylestradiol	-	757560	
2.3.1.37	hexamethylene diacetamide	induction of enzyme expression, erythroleukemia cells	486847	
2.3.1.37	Lubrol	activates, fetal enzyme	486841	
2.3.1.37	additional information	1-2 low molecular-weight compounds which stimulate or stabilize activity found by dialysis of crude extract	486815	
2.3.1.37	additional information	iron depletion does not increase isoform II promotor activity	486846	
2.3.1.37	NaCl	required for maximal activity	486812	
2.3.1.37	native activator protein	purified from cell extract	486830	
2.3.1.37	native activator protein	purified from hepatic extract	486822	
2.3.1.37	norethandrolone	-	757560	
2.3.1.37	Norethindrone	-	757560	
2.3.1.37	O2	1%, 3fold increase in expression level, promotor activation in transiently transfected HeLa cells, hypoxia-inducible erythroid-isoform	486846	
2.3.1.37	Phenobarbitone	-	757560	
2.3.1.37	Phenylbutazone	-	757560	
2.3.1.37	phosphate	enzyme is maximally active in presence of 0.005 mM phosphate	486817	
2.3.1.37	vitamin B12	stimulates	486839